How long has stelara been on the market?

Stelara (ustekinumab) was first approved by the U.S. Food and Drug Administration in 2009 for the treatment of moderate‑to‑severe plaque psoriasis. Since that initial approval it has also received approvals for psoriatic arthritis (2011), Crohn’s disease (2012), and ulcerative colitis (2019).

So, as of 2026, Stelara has been available on the market for about 17 years.